Theratechnologies Inc. (TSE:TH – Get Free Report)’s share price rose 29.9% on Wednesday . The company traded as high as C$2.99 and last traded at C$2.87. Approximately 168,744 shares changed hands during trading, an increase of 248% from the average daily volume of 48,537 shares. The stock had previously closed at C$2.21.
Analyst Upgrades and Downgrades
Separately, Research Capitl upgraded Theratechnologies to a “strong-buy” rating in a report on Friday, February 14th.
Check Out Our Latest Research Report on TH
Theratechnologies Stock Up 9.0 %
Theratechnologies Company Profile
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.
Recommended Stories
- Five stocks we like better than Theratechnologies
- How to Buy Cheap Stocks Step by Step
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Tesla Stock: Has the Mother of All Comebacks Begun?
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Palantir Setting Up to Be a Big Winner With New Defense Spending
Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.